SLN 241220 7.50C (SLN241220C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SLN241220C7500

Watchlist

1.70
+1.30+325.00%

15min DelayClose Nov 21 16:00 ET

1.70High0.75Low

Intraday

5D
Daily

News

Express News | Silence Therapeutics PLC : Jefferies Cuts Target Price to $31 From $38
ReutersNov 21 01:07 ET
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT NewswiresNov 20 11:08 ET
SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Zacks Nov 20 10:30 ET
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
BenzingaNov 19 15:34 ET
Silence Therapeutics Weakness After AHA Updates 'Overdone,' Says BMO Capital
TipRanksNov 19 12:55 ET
SILENCE THERAPEUTICS PLC SPONSORED ADR Trading Halted, Volatility Trading Pause
TipRanksNov 19 11:15 ET

Comments

Johnny Mnemonic

Yesterday 04:53

still severely oversold

Johnny Mnemonic

Yesterday 03:29

shorts gonna get burned if they don't get out, there's this much outflow and still pushing, be careful

Stock_Drift

Nov 18 14:13

$Silence Therapeutics (SLN.US)$

Moomoo AI

Feb 3 06:08

Despite strong growth, Silence Therapeutics' high P/S ratio and weak revenue outlook suggest a risk of share price decline. Analysts lack confidence in a business turnaround, indicating potential risk for shareholders and potential investors.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 26% But Growth Is Lacking

Moomoo AI

Nov 27, 2023 04:17

Analysts' confidence appears low for Silence Therapeutics' business turnaround. The high P/S ratio and expected revenue decline suggest unsustainable current price levels which may erode current sentiment towards the stock.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 65% But Growth Is Lacking